Can gabapentin (anticonvulsant) help with musculoskeletal pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin for Musculoskeletal Pain

Gabapentin is not recommended as a first-line treatment for musculoskeletal pain, as it has limited evidence supporting its efficacy for this specific type of pain. 1

Evidence for Gabapentin in Different Pain Types

Neuropathic Pain

  • Gabapentin is considered a first-line treatment for neuropathic pain conditions, including diabetic neuropathy and postherpetic neuralgia 1, 2
  • For neuropathic pain, gabapentin works by binding to calcium channels (α-δ subunits) in the brain and spinal cord, inhibiting the release of excitatory neurotransmitters involved in pain 1
  • Effective doses for neuropathic pain typically range between 900-3600 mg/day in divided doses 1
  • In older adults, lower starting doses (100-200 mg/day) with gradual titration are recommended due to increased risk of side effects 1

Musculoskeletal Pain

  • For musculoskeletal pain conditions such as multifocal joint pain and low back pain, the preferred adjuvant analgesics include:
    • Antidepressants (particularly duloxetine and TCAs) 1
    • Topical analgesics for localized pain 1
    • NSAIDs for inflammatory components 1
  • Gabapentin is not specifically recommended for musculoskeletal pain in clinical guidelines 1
  • Recent evidence suggests potential concerns with long-term gabapentinoid use on musculoskeletal tissues, including increased fracture risk 3

Recommendations for Musculoskeletal Pain Management

First-Line Treatments

  • NSAIDs and acetaminophen for inflammatory and non-inflammatory musculoskeletal pain 1
  • Topical analgesics (lidocaine, salicylate, capsaicin) for localized pain 1
  • Serotonin-norepinephrine reuptake inhibitors (SNRIs), particularly duloxetine, for chronic musculoskeletal pain 1

Second-Line Treatments

  • Tricyclic antidepressants (preferably secondary amines like nortriptyline or desipramine to minimize side effects) 1
  • Physical therapy and exercise programs 4
  • Cognitive behavioral therapy and other non-pharmacological approaches 4

Side Effects and Precautions with Gabapentin

  • Common side effects include somnolence (14%), dizziness (19%), peripheral edema (7%), and gait disturbance (9%) 2
  • Side effects can be particularly problematic in older adults 1
  • If gabapentin is used for pain with neuropathic components, start at low doses (100-200 mg/day in older adults) and titrate slowly 1
  • Monitor for effectiveness and discontinue if not providing adequate pain relief 1

Special Considerations

  • For fibromyalgia and chronic widespread pain with muscle involvement, evidence supports trials of antidepressants (duloxetine and TCAs) and pregabalin rather than gabapentin 1
  • So-called "muscle relaxants" (methocarbamol, carisoprodol, etc.) are not recommended for chronic musculoskeletal pain due to limited evidence and potential adverse effects 1
  • For pain with mixed neuropathic and musculoskeletal components, a targeted approach addressing both components may be necessary 1, 4

In conclusion, while gabapentin has established efficacy for neuropathic pain conditions, it should not be considered a first-line treatment for purely musculoskeletal pain. Treatment should focus on evidence-based options including NSAIDs, acetaminophen, topical analgesics, and certain antidepressants, along with non-pharmacological approaches.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

The Cochrane database of systematic reviews, 2014

Guideline

Safe Management of Chronic Neuromuscular Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.